Lack of comparative research into acne treatments could limit their effectiveness

30 Aug 2011 00:01:00.000

PA 256/11

Acne is a chronic disease which can be painful and disfiguring. Many treatments are publicised as cures for acne, often at considerable expense to the sufferer and the healthcare system.

A new clinical review by experts at The University of Nottingham says there is very little research evidence to show which treatments work best and whether expensive treatments are any better than traditional ones.

The review, led by a team from the Centre for Evidence Based Dermatology (CEBD), at The University of Nottingham, along with colleagues from the University of Colorado, Denver, highlights that the long-term use of antibiotics to treat acne might also contribute to bacterial resistance. As a result they say there is an increasing urgency to test treatments and develop more effective non-antibiotic therapies. The results of their study are published online in The Lancet today Tuesday 30 August 2011.

Click here for full story

Hywel Williams, Professor of Dermato-Epidemiology and Director of the CEBD said: “The large number of products and product combinations, and the scarcity of comparative studies, has led to disparate guidelines with few recommendations being evidence-based. As a result, even recent guidelines (including those from the Global Alliance and the American Academy of Dermatology) are based on the opinion of experts. This is of concern because without evidence to support guidelines there is the potential for conflicts of interest. What we would like to see is a great deal more comparative effectiveness research to help reduce the plethora of current therapeutic options for initiation and maintenance treatment.”

Acne affects almost all young people to some degree, up to 20% of them are left with facial scarring. The condition can also persist into adulthood, so it needs to be considered as a chronic disease and not just something that clears up after a couple of years. Around 14% of patients with acne experience sufficient distress related to their facial appearance to be diagnosed the with psychological condition dysmorphobia – an excessive pre-occupation with an imaginary or minor defect in a facial feature or localised part of the body.

Relatively little is known about the causes of acne and the treatment for it. Factors such as family history, diet, sunlight, and skin hygiene have all been implicated, but supportive evidence is lacking. So acne sufferers may be going to great lengths to change their lifestyle for not reason at all. A recent study suggested that Western diets might play a role in the disease because of the apparent absence of acne in non-Westernised people in Papua New Guinea and Paraguay, but this has yet to be proven.



Professor Williams said: “Almost half of recently published acne trials contain serious flaws that could be overcome by better reporting. The absence of trials with active comparators is a significant handicap to shared clinical decision making. Clinical trials of cost-effectiveness of different strategies for initial treatment and maintenance therapy of acne are needed.


“This lack of well-conducted research to test over-the-counter and prescription therapies is putting patients at risk of ineffective treatment and makes treatment decisions for patients and doctors very difficult. This has prompted the Institute of Medicine in the USA to target comparative-effectiveness research on acne therapy as one of the top 100 targets for national research.”

The study shows that there is also considerable concern that the overuse of antibiotics to treat acne will lead to the development of antibiotic resistance, especially if they are used for long periods at low doses. The authors suggest restricting the use of antibiotics as maintenance treatment because alternatives such as benzoyl peroxide may work just as well. In the distant future vaccines might hold some promise.

Professor Williams and his team are calling for new research into the comparative effectiveness of common topical and systemic therapies and to improve the understanding of the natural history, specific types, and triggers of acne, and how treatment affects the course of this poorly understood disease.

Professor Willliams said: “Acne has been dismissed as a trivial self-limiting teenage phase for too long. It is chronic condition with significant psychological effects at a critical time of a young person’s development. Apart from isotretinoin, which can have some uncommon but serious side effects, I am not convinced that any of the other treatments actually clear acne. What is needed is a whole rethink about acne research into which treatments should be started first, how well do commonly used treatment compare against each other, which treatments should be used for maintaining control and which combinations are best.”


— Ends —



Notes to editors:


The University of Nottingham, described by The Sunday Times University Guide 2011 as ‘the embodiment of the modern international university’, has award-winning campuses in the United Kingdom, China and Malaysia. It is ranked in the UK's Top 10 and the World's Top 75 universities by the Shanghai Jiao Tong (SJTU) and the QS World University Rankings. It was named ‘Europe’s greenest university’ in the UI GreenMetric World University Ranking, a league table of the world’s most environmentally-friendly higher education institutions, which ranked Nottingham second in the world overall.

The University is committed to providing a truly international education for its 40,000 students, producing world-leading research and benefiting the communities around its campuses in the UK and Asia.

More than 90 per cent of research at The University of Nottingham is of international quality, according to the most recent Research Assessment Exercise, with almost 60 per cent of all research defined as ‘world-leading’ or ‘internationally excellent’. Research Fortnight analysis of RAE 2008 ranked the University 7th in the UK by research power.

The University’s vision is to be recognised around the world for its signature contributions, especially in global food security, energy & sustainability, and health.

More news from the University at:

Story credits

More information is available from Professor Hywel Williams, at The University of Nottingham, on +44 (0)115 823 1047, or Tony Kirby at The Lancet on +44 (0)207 4244949,

Lindsay Brooke

Lindsay Brooke - Media Relations Manager

Email: Phone: +44 (0)115 951 5751 Location: University Park

Additional resources

No additional resources for this article

Related articles

Media Relations - External Relations

The University of Nottingham
YANG Fujia Building
Jubilee Campus
Wollaton Road
Nottingham, NG8 1BB

telephone: +44 (0) 115 951 5798